Related Experiment Videos
Risk factors for diffuse and focal macular edema
Pedro Romero Aroca1, Mercè Salvat, Juan Fernández
1Ophthalmologic Service, Departamento de Medicina y Cirugía, Hospital Universitario Sant Joan de Reus, Universidad Rovira y Virgili, ReusSpain. promero@grupsagessa.com
Journal of Diabetes and Its Complications
|June 23, 2004
Summary
Diabetic macular edema risk factors differ between focal and diffuse types. Diffuse edema is linked to panretinal laser, hypertension, nephropathy, and insulin. Focal edema is associated with insulin, hypertension, and HbA1c levels.
Area of Science:
- Ophthalmology
- Endocrinology
- Epidemiology
Background:
- Diabetic macular edema (DME) is a leading cause of vision loss in diabetic patients.
- Existing literature lacks differentiation between risk factors for focal and diffuse DME.
- Understanding these differences is crucial for targeted prevention and treatment strategies.
Purpose of the Study:
- To identify and differentiate epidemiological risk factors influencing the development of focal versus diffuse diabetic macular edema.
- To compare risk factor profiles between patients with diffuse DME, focal DME, and diabetic retinopathy without DME.
Main Methods:
- A 4-year prospective study involving three groups of Type II diabetic patients: diffuse DME (Group A), focal DME (Group B), and diabetic retinopathy without DME (Group C).
- Groups were matched for sex, age, and diabetes duration.
- Key risk factors analyzed included insulin treatment, diastolic hypertension, diabetic nephropathy, HbA1c levels, type of retinopathy, prior panretinal photocoagulation, and lipid profiles.
Main Results:
- Discriminant analysis revealed distinct risk factor patterns for each group.
- Diffuse DME (Group A) was significantly associated with prior panretinal laser treatment, diastolic hypertension, diabetic nephropathy, and insulin treatment.
- Focal DME (Group B) was linked to insulin treatment, diastolic hypertension, and elevated HbA1c levels. Group C (no DME) showed associations with diastolic hypertension and insulin treatment.
Conclusions:
- Patients with focal macular edema share similar epidemiological characteristics with those who have diabetic retinopathy but no macular edema.
- Patients with diffuse macular edema present a distinct epidemiological profile compared to both focal DME and no DME groups.
- These findings highlight the need for tailored management approaches based on the specific type of diabetic macular edema.